1. 53. TUCATINIB VS PLACEBO ADDED TO TRASTUZUMAB AND CAPECITABINE FOR PATIENTS WITH PREVIOUSLY TREATED HER2+ METASTATIC BREAST CANCER (MBC) WITH BRAIN METASTASES (BM) (HER2CLIMB). (4th August 2020) Authors: Lin, Nancy; Murthy, Rashmi; Anders, Carey; Borges, Virginia; Hurvitz, Sara; Loi, Sherene; Abramson, Vandana; Bedard, Philippe; Oliveira, Mafalda; Zelnack, Amelia; DiGiovanna, Michael; Bachelot, Thomas; Chien, A Jo; O'Regan, Ruth; Wardley, Andrew; Mueller, Volkmar; Carey, Lisa; McGoldrick, Suzanne... Journal: Neuro-oncology advances Issue: Volume 2(2020)Supplement 2 Page Start: ii11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019) Authors: Piprot, C; Cals, L; Chaigneau, L; Demarchi, F; N'Guyen, T; Stein, U; Villanueva, C; Bréau, JL; Chouahnia, AK; Saintigny, P; Boué, F; deSaint-Hilaire, P; Guimont, I; Grossat, N; Valenza, B; Lévy, E; Médioni, J; Delbaldo, C; Grenier, J; Pouessel, D Journal: Lancet Issue: Volume 393:Issue 10191(2019) Page Start: 2591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019) Authors: Pivot, Xavier; Romieu, Gilles; Debled, Marc; Pierga, Jean-Yves; Kerbrat, Pierre; Bachelot, Thomas; Lortholary, Alain; Espié, Marc; Fumoleau, Pierre; Serin, Daniel; Jacquin, Jean-Philippe; Jouannaud, Christelle; Rios, Maria; Abadie-Lacourtoisie, Sophie; Venat-Bouvet, Laurence; Cany, Laurent; Catal... Journal: Lancet Issue: Volume 393:Issue 10191(2019) Page Start: 2591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A functional interplay between ZNF217 and Estrogen Receptor alpha exists in luminal breast cancers. Issue 8 (10th June 2014) Authors: Nguyen, Nhan T.; Vendrell, Julie A.; Poulard, Coralie; Győrffy, Balázs; Goddard-Léon, Sophie; Bièche, Ivan; Corbo, Laura; Le Romancer, Muriel; Bachelot, Thomas; Treilleux, Isabelle; Cohen, Pascale A. Journal: Molecular oncology Issue: Volume 8:Issue 8(2014:Dec.) Page Start: 1441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A new era of improving progression-free survival with dual blockade in postmenopausal HR+, HER2− advanced breast cancer. Issue 2 (February 2015) Authors: Jerusalem, Guy; Bachelot, Thomas; Barrios, Carlos; Neven, Patrick; Di Leo, Angelo; Janni, Wolfgang; de Boer, Richard Journal: Cancer treatment reviews Issue: Volume 41:Issue 2(2015) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study. Issue 2 (December 2016) Authors: Diéras, Véronique; Bachelot, Thomas; Campone, Mario; Isambert, Nicolas; Joly, Florence; Tourneau, Christophe; Cassier, Philippe; Bompas, Emmanuelle; Fumoleau, Pierre; Noal, Sabine; Orsini, Christine; Jimenez, Marta; Imbs, Diane; Chatelut, Etienne Journal: Oncology and therapy Issue: Volume 4:Issue 2(2016) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial). (November 2021) Authors: Campone, Mario; Bachelot, Thomas; Treilleux, Isabelle; Pistilli, Barbara; Salleron, Julia; Seegers, Valérie; Arnedos, Monica; Loussouarn, Delphine; Wang, Qing; Vanlemmens, Laurence; Jimenez, Marta; Rios, Maria; Diéras, Véronique; Leroux, Agnès; Paintaud, Gilles; Rezai, Keyvan; André, Fabrice; Lio... Journal: European journal of cancer Issue: Volume 158(2021) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A response letter to comments on "Contemporary outcomes of metastatic breast cancer among 22, 000 women from the multicentre ESME cohort 2008-2016". (November 2020) Authors: Deluche, Elise; Antoine, Alison; Bachelot, Thomas; Robain, Mathieu; Perol, David; Delaloge, Suzette Journal: European journal of cancer Issue: Volume 140(2020) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Advanced Stage Breast Cancer Lifestyle and Exercise (ABLE) Feasibility Study: Preliminary Results. (November 2017) Authors: Delrieu, Lidia; Perol, Olivia; Friedenreich, Christine; Febvey, Olivia; Martin, Agnes; Fervers, Béatrice; Bachelot, Thomas; Dufresne, Armelle; Heudel, Pierre-Etienne; Trédan, Olivier; Touillaud, Marina; Pialoux, Vincent Journal: Breast Issue: Volume 36(2017)Supplement 1 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial. Issue 16 (December 2015) Authors: Cortés, Javier; Dieras, Véronique; Ro, Jungsil; Barriere, Jérôme; Bachelot, Thomas; Hurvitz, Sara; Le Rhun, Emilie; Espié, Marc; Kim, Sung-Bae; Schneeweiss, Andreas; Sohn, Joo Hyuk; Nabholtz, Jean-Marc; Kellokumpu-Lehtinen, Pirkko-Liisa; Taguchi, Julie; Piacentini, Federico; Ciruelos, Eva; Bono, ... Journal: Lancet oncology Issue: Volume 16:Issue 16(2015) Page Start: 1700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗